BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28933643)

  • 1. Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma.
    Maziarz RT; Hao Y; Guerin A; Gauthier G; Gauthier-Loiselle M; Thomas SK; Eldjerou L
    Leuk Lymphoma; 2018 May; 59(5):1133-1142. PubMed ID: 28933643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
    Ren J; Asche CV; Shou Y; Galaznik A
    J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare Resource Utilization and Cost Associated with Allogeneic Hematopoietic Stem Cell Transplantation: A Scoping Review.
    Kim NV; McErlean G; Yu S; Kerridge I; Greenwood M; Lourenco RA
    Transplant Cell Ther; 2024 May; 30(5):542.e1-542.e29. PubMed ID: 38331192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year direct costs of acute lymphoblastic leukemia pediatric patients undergoing allogeneic stem cell transplant.
    Maziarz RT; Guérin A; Gauthier G; Heroux J; Zhdanava M; Wu EQ; Thomas SK; Chen L
    Int J Hematol Oncol; 2016 Sep; 5(2):63-75. PubMed ID: 30302205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA.
    Morrison VA; Bell JA; Hamilton L; Ogbonnaya A; Shih HC; Hennenfent K; Eaddy M; Shou Y; Galaznik A
    Future Oncol; 2018 Oct; 14(25):2627-2642. PubMed ID: 29911900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost associated with hematopoietic stem cell transplantation: a retrospective claims data analysis in Germany.
    Mayerhoff L; Lehne M; Hickstein L; Salimullah T; Prieur S; Thomas SK; Zhang J
    J Comp Eff Res; 2019 Jan; 8(2):121-131. PubMed ID: 30517020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
    Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
    Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trajectories, healthcare resource use, and costs of long-term hematopoietic stem cell transplantation survivors: a latent class analysis.
    Zhou J; Nutescu EA; Han J; Calip GS
    J Cancer Surviv; 2020 Jun; 14(3):294-304. PubMed ID: 31897877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients.
    Robin C; Hémery F; Dindorf C; Thillard J; Cabanne L; Redjoul R; Beckerich F; Rodriguez C; Pautas C; Toma A; Maury S; Durand-Zaleski I; Cordonnier C
    BMC Infect Dis; 2017 Dec; 17(1):747. PubMed ID: 29207952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
    Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
    Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
    Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous hematopoietic stem cell transplantation for patients with diffuse large B-cell lymphoma: a retrospective study].
    Lu XL; Li Y; Huang WR; Guo YL; Zhao XL; Lu N; Zhu HY; Wang QS; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):617-22. PubMed ID: 23815909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation.
    Preussler JM; Meyer CL; Mau LW; Majhail NS; Denzen EM; Edsall KC; Farnia SH; Saber W; Burns LJ; Vanness DJ
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):1021-1028. PubMed ID: 28263920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role and progress of allogeneic hematopoietic stem cell transplantation in the treatment of refractory/relapsed diffuse large B-cell lymphoma].
    Cao LQ; Mo XD
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):308-312. PubMed ID: 38716606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
    Hamadani M; Awan FT; Elder P; Lin TS; Porcu P; Benson DM; Blum KA; Devine SM
    Leuk Lymphoma; 2008 Oct; 49(10):1893-8. PubMed ID: 18949613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with third stem cell transplant from an allogeneic donor for a patient with relapsed diffuse large B-cell lymphoma.
    Takasaki H; Ishii Y; Yamamoto W; Tsuchihashi H; Motomura S; Tomita N; Ishigatsubo Y; Sakai R
    Exp Clin Transplant; 2013 Apr; 11(2):199-202. PubMed ID: 23425447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
    Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
    Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of transplantation and some clinical factors on prognosis of patients with diffuse large B-cell lymphoma].
    Zhao SX; Han Y; Zhu Q; Wang Q; Zhang WJ; Chen XC; Sun AN; Jin ZM; Qiu HY; Tang XW; Fu ZZ; He GS; Miao M; Ma X; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):623-7. PubMed ID: 23815910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection and associated hospitalization and costs among individuals undergoing allogeneic hematopoietic stem cell transplant.
    Schelfhout J; Brown H; House JA; Raval AD
    Curr Med Res Opin; 2020 Jan; 36(1):43-50. PubMed ID: 31490097
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase.
    Jabbour EJ; Lin J; Siegartel LR; Lingohr-Smith M; Menges B; Makenbaeva D
    J Med Econ; 2017 Sep; 20(9):1007-1012. PubMed ID: 28681664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.